The Second Edition FACT Common Standards for Cellular Therapies was published March 15, 2019. Programs accredited under the FACT Common Standards must be in compliance with these Standards by June 15, 2019.

The major objective of these Standards is to promote quality medical and laboratory practice in a broad range of cellular therapies. These Standards represent basic principles of quality in cellular therapy that can be applied to any cell source or therapeutic application, and are intended to be used throughout product development and clinical trials.

These Standards apply to:

  • Cells collected from non-hematopoietic sources (e.g., adipose tissue).
  • Cells collected from hematopoietic sources for non-homologous use (e.g., mesenchymal stromal cells for cardiac repair).

The updated Standards and summary of changes are available on the FACT website for reference. Printed copies of the Standards may be purchased from the FACT store. Read more

FACT Common Standards, Second Edition
Purchase Printed Copies
Summary of Changes to FACT Common Standards, Second Edition
FACT Common Standards Crosswalk First to Second Edition
FACT Common Standards Crosswalk Second to First Edition



FACT Consulting

Accreditation Success Story

The Héma-Québec Public Cord Blood Bank (CBB) was created in 2004 to meet the needs of Quebecers and to contribute to the international effort towards a high-quality global inventory of cord blood units. Read more